- Founded
- 2017
- Employees
- 101-250
- Total Funding
- $351M
Founded by Alan Ashworth, José Baselga, Timothy K. Lu in 2017.
About Tango Therapeutics
Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing. The Tango labs and offices are located at 201 Brookline Avenue, in the Fenway area of Boston, Massachusetts.
Leadership at Tango Therapeutics
The team at the top of the org chart.
Barbara Weber
Chairperson of the Board
14 reports
Drew Sansone
Chief Regulatory Officer
1 report
Yong Liu
Executive Director
11 reports
Board
Alan Ashworth
Scientific Advisor
Ulrich Elling
Scientific Advisor
William G. Kaelin
Scientific Advisor
Antoni Ribas
Scientific Advisor
John G. Doench
Scientific Advisor
Alexis Borisy
Director
Open Jobs at Tango Therapeutics (4)
Similar companies hiring
Top employers in Health Care